Skip to Content

DAN A23 (Ranitidine Hydrochloride 300 mg)

Pill with imprint DAN A23 is Yellow, Elliptical / Oval and has been identified as Ranitidine Hydrochloride 300 mg. It is supplied by Schein.

Ranitidine is used in the treatment of duodenal ulcer; erosive esophagitis; gerd; duodenal ulcer prophylaxis; cutaneous mastocytosis and belongs to the drug class H2 antagonists. There is no proven risk in humans during pregnancy. Ranitidine 300 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for DAN A23

Ranitidine hydrochloride 300 mg DAN A23 Front
Ranitidine hydrochloride 300 mg DAN A23 Back

Ranitidine Hydrochloride

Imprint
DAN A23
Strength
300 mg
Color
Yellow
Shape
Elliptical / Oval
Availability
Rx and/or OTC
Drug Class
H2 antagonists
Pregnancy Category
B - No proven risk in humans
CSA Schedule
Not a controlled drug
Labeler / Supplier
Schein
National Drug Code (NDC)
00364-2634

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.